Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


30.12.2018

1 Allergy
1 Am J Respir Cell Mol Biol
11 Ann Allergy Asthma Immunol
3 Eur Respir J
3 J Allergy Clin Immunol
3 J Asthma
1 J Investig Allergol Clin Immunol
1 JAMA
2 Lancet Respir Med
1 N Engl J Med
1 Pediatr Pulmonol
3 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Allergy

  1. DEVILLIER P, Molimard M, Ansolabehere X, Bardoulat I, et al
    Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France.
    Allergy. 2018 Dec 27. doi: 10.1111/all.13705.
    PubMed     Text format     Abstract available


    Am J Respir Cell Mol Biol

  2. ZHU L, An L, Ran D, Lizarraga R, et al
    The Club Cell Marker SCGB1A Downstream of FOXA1 is Reduced in Asthma.
    Am J Respir Cell Mol Biol. 2018 Dec 21. doi: 10.1165/rcmb.2018-0199.
    PubMed     Text format     Abstract available


    Ann Allergy Asthma Immunol

  3. DESAI M, Oppenheimer J
    Biologics in allergic and immunologic diseases: promises and challenges in the era of personalized medicine.
    Ann Allergy Asthma Immunol. 2018 Feb 5. pii: S1081-1206(18)30063.
    PubMed     Text format    

  4. ESTEBAN CA, Everhart R, Kopel SJ, Klein RB, et al
    Authors' response.
    Ann Allergy Asthma Immunol. 2018;120:224-225.
    PubMed     Text format    

  5. SATO S, Saito J
    Authors' response.
    Ann Allergy Asthma Immunol. 2018;120:341.
    PubMed     Text format    

  6. SEGHEZZO S, Arnold DH, Gay JC, Moore PE, et al
    Authors' response.
    Ann Allergy Asthma Immunol. 2018;120:450.
    PubMed     Text format    

  7. SACO TV, Pepper A, Casale TB
    Uses of biologics in allergic diseases: what to choose and when.
    Ann Allergy Asthma Immunol. 2018 Feb 27. pii: S1081-1206(18)30156.
    PubMed     Text format    

  8. KOTSIOU OS, Gourgoulianis KI
    Fractional exhaled nitric oxide: Signaling lung function changes in obstructive lung diseases.
    Ann Allergy Asthma Immunol. 2018;120:340.
    PubMed     Text format    

  9. DINAKAR C, Khan DA, Fineman SM, Lang DM, et al
    Biologics.
    Ann Allergy Asthma Immunol. 2018;120:354-356.
    PubMed     Text format    

  10. GUR CETINKAYA P, Esenboga S, Uysal Soyer O, Tuncer A, et al
    Subcutaneous venom immunotherapy in children: Efficacy and safety.
    Ann Allergy Asthma Immunol. 2018;120:424-428.
    PubMed     Text format     Abstract available

  11. RANK MA, Oppenheimer JJ
    "Asthma Biologics: Underuse, Overuse, and Best Use?"
    Ann Allergy Asthma Immunol. 2018 Dec 19. pii: S1081-1206(18)31536.
    PubMed     Text format    

  12. KUROSAWA M, Sutoh E
    Severe uncontrolled eosinophilic asthma, which responded to benralizumab after failure to respond to mepolizumab.
    Ann Allergy Asthma Immunol. 2018 Dec 19. pii: S1081-1206(18)31534.
    PubMed     Text format    

  13. WEINBERGER M
    Do we need to keep playing this tune?
    Ann Allergy Asthma Immunol. 2018;120:449.
    PubMed     Text format    


    Eur Respir J

  14. PAVLIDIS S, Takahashi K, Kwong FNK, Xie J, et al
    "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00938-2018.
    PubMed     Text format     Abstract available

  15. PATEL S, Cole AD, Nolan CM, Barker RE, et al
    Pulmonary rehabilitation in bronchiectasis: a propensity matched study.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01264-2018.
    PubMed     Text format     Abstract available

  16. TONGA KO, Berend N, Thamrin C, Farah CS, et al
    Lung elastic recoil and ventilation heterogeneity of diffusion-dependent airways in older people with asthma and fixed airflow obstruction.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01028-2018.
    PubMed     Text format    


    J Allergy Clin Immunol

  17. REESE SE, Xu CJ, den Dekker HT, Lee MK, et al
    Epigenome-wide Meta-analysis of DNA Methylation and Childhood Asthma.
    J Allergy Clin Immunol. 2018 Dec 20. pii: S0091-6749(18)32788.
    PubMed     Text format     Abstract available

  18. DAHLIN A, Sordillo JE, Ziniti J, Iribarren C, et al
    Large-scale, multi-ethnic genome-wide association study identifies novel loci contributing to asthma susceptibility in adults.
    J Allergy Clin Immunol. 2018 Dec 19. pii: S0091-6749(18)32779.
    PubMed     Text format     Abstract available

  19. HANANIA NA, Chipps BE, Griffin NM, Yoo B, et al
    Omalizumab effectiveness in Asthma COPD overlap: post hoc analysis of PROSPERO study.
    J Allergy Clin Immunol. 2018 Dec 18. pii: S0091-6749(18)32730.
    PubMed     Text format     Abstract available


    J Asthma

  20. TARRAF HN, Masoud HH, Zidan M, Wahba B, et al
    Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population.
    J Asthma. 2018 Dec 28:1-7. doi: 10.1080/02770903.2018.1553051.
    PubMed     Text format     Abstract available

  21. TRAN P, Tran L
    Comparisons between 2015 US asthma prevalence and two measures of asthma burden by racial/ethnic group.
    J Asthma. 2018 Dec 28:1-11. doi: 10.1080/02770903.2018.1556686.
    PubMed     Text format     Abstract available

  22. PAPLINSKA-GORYCA M, Nejman-Gryz P, Proboszcz M, Kwiecien I, et al
    Expression of TSLP and IL-33 receptors on sputum macrophages of asthma patients and healthy subjects.
    J Asthma. 2018 Dec 27:1-10. doi: 10.1080/02770903.2018.1543435.
    PubMed     Text format     Abstract available


    J Investig Allergol Clin Immunol

  23. GOMULKA K, Liebhart J, Jaskula E, Lange A, et al
    VEGF -2549 -2567 del18 polymorphism and irreversible bronchoconstriction in asthmatics.
    J Investig Allergol Clin Immunol. 2018 Dec 21:0. doi: 10.18176/jiaci.0369.
    PubMed     Text format     Abstract available


    JAMA

  24. ABOUMATAR H, Naqibuddin M, Chung S, Chaudhry H, et al
    Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
    JAMA. 2018;320:2335-2343.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  25. YANG IV
    DNA methylation signatures of atopy and asthma.
    Lancet Respir Med. 2018 Dec 21. pii: S2213-2600(18)30504.
    PubMed     Text format    

  26. FORNO E, Wang T, Qi C, Yan Q, et al
    DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study.
    Lancet Respir Med. 2018 Dec 21. pii: S2213-2600(18)30466.
    PubMed     Text format     Abstract available


    N Engl J Med

  27. MOJICA JE, Richards CJ, Husseini JS, Hariri LP, et al
    Case 40-2018: A 47-Year-Old Woman with Recurrent Sinusitis, Cough, and Bronchiectasis.
    N Engl J Med. 2018;379:2558-2565.
    PubMed     Text format    


    Pediatr Pulmonol

  28. SORDILLO JE, McGeachie M, Lutz SM, Lasky-Su J, et al
    Longitudinal analysis of bronchodilator response in asthmatics and effect modification of age-related trends by genotype.
    Pediatr Pulmonol. 2018 Dec 25. doi: 10.1002/ppul.24219.
    PubMed     Text format     Abstract available


    PLoS One

  29. WANG JB, Olgin JE, Nah G, Vittinghoff E, et al
    Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study.
    PLoS One. 2018;13:e0198681.
    PubMed     Text format     Abstract available

  30. CALLE RUBIO M, Soriano JB, Lopez-Campos JL, Soler-Cataluna JJ, et al
    Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
    PLoS One. 2018;13:e0198777.
    PubMed     Text format     Abstract available

  31. YANG TH, Chuang FC, Kuo HC
    Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction.
    PLoS One. 2018;13:e0198764.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: